South Korea Ranks in GSK’s Global Top 10 for Clinical Research, with Over 70 Trials Underway
"South Korea is among the top 10 markets in GSK’s global clinical research. More than 70 clinical programs are currently underway here.
Search results for "new drug development"
Daegu Wins Bid to Host 2034 World Congress of Basic & Clinical Pharmacology
Daegu has been selected to host the 2034 World Congress of Basic & Clinical Pharmacology (WCP 2034), marking the first time South Korea will hold the...
Fueling the Future of Biohealth: InterBiz Forum Opens in Jeju With a Record 1,500 Tech Deals
The 24th InterBiz Bio Partnering & Investment Forum 2026, a premier biohealth technology deal-making event, opened...
Why Surgeons are Tracking the Rise of 'Pharmulator': The Next Frontier in Drug Development
The new drug development platform Pharmulator™ has officially made its debut on the international stage—not at a...
Gene Editing Offers New Hope for Rare, Exhausting Kidney Disease
Researchers have used gene editing to insert a functional gene into stem cells derived from patients with a rare...
Internal Radiation Treatment Could Expand Pancreatic Cancer Surgery Options as Samsung Medical Center Partners with Alpha Tau
Pancreatic cancer carries a five-year relative survival rate of just 17.0%, the lowest among all major cancers,...
Lexraza Developer and Lilly Obesity Chief to Headline Global Clinical Trial Summit in Seoul
What will it take to build on the success of Lexraza, South Korea’s landmark lung cancer drug, and propel it into the...
From Returned Candidate to Homegrown Breakthrough: Hanmi’s ‘Epe’ Prepares to Challenge Wegovy and Mounjaro
Efpeglenatide, a drug candidate whose development rights were once returned by a global pharmaceutical giant, is...
Exclusive: Boryung’s Spun-Off Sales Unit Sets Pay Above Parent Levels, Top 40% Eligible for 100 Million-Plus Won
Boryung is setting compensation at its soon-to-be spun-off prescription drug sales division above parent-company...
‘Singapore Is the Bridge, Not the Destination’: Novo Holdings Connects Asian Biotech to Global Capital
Global life sciences investment firm Novo Holdings is bringing its proven European biotech company-building playbook to...